N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes

Chemical Communications

Volumn 51, Issue 8, 2015, Pages 1410-1413

  Wang, Y ^a   McAlpine, S R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90 INHIBITOR; HEAT SHOCK TRANSCRIPTION FACTOR 1; MESSENGER RNA; SM 122; TANESPIMYCIN; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; CYCLOPEPTIDE; HEAT SHOCK PROTEIN 90; MACROCYCLIC LACTAM; SM122 CYCLIC PEPTIDE;

ARTICLE; BINDING AFFINITY; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION; HCT116 CELL LINE; HEAT SHOCK; HEAT SHOCK RESPONSE; HUMAN; HUMAN CELL; IC50; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN RENATURATION; RETICULOCYTE LYSATE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; NEOPLASM; PROTEIN CONFORMATION;

BENZOQUINONES; HCT116 CELLS; HEAT-SHOCK RESPONSE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; NEOPLASMS; PEPTIDES, CYCLIC; PHENOTYPE; PROTEIN CONFORMATION; PROTEIN FOLDING; RNA, MESSENGER;

EID: 84925069996     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c4cc07284g     Document Type: Article

References (27)

1. J. E. Bohonowych, U. Gopal and J. S. Isaacs, J. Oncol., 2010, 2010, 412-485.
2. G. Chiosis, H. JHuezo, N. Rosen, E. Mimgaugh, L. Whitesell and L. Neckers, Mol. Cancer Ther., 2003, 2, 123-129.
3. J. R. McConnell and S. R. McAlpine, Bioorg. Med. Chem. Lett., 2013, 23, 1923-1928.
4. S. Modi, C. Saura, C. Henderson, N. U. Lin, R. Mahtani, J. Goddard, E. Rodenas, C. Hudis, J. O'Shaughnessy and J. Baselga, Breast Cancer Res. Treat., 2013, 139, 107-113.
5. N. Gandhi, A. T. Wild, S. T. Chettiar, K. Aziz, Y. Kato, R. P. Gajula, R. D. Williams, J. A. Cades, A. Annadanam, D. Song, Y. Zhang, R. K. Hales, J. M. Herman, E. Armour, T. L. DeWeese, E. M. Schaeffer and P. T. Tran, Cancer Biol. Ther., 2013, 14, 347-356.
6. J. W. Goldman, R. N. Raju, G. A. Gordon, I. El-Hariry, F. Teofilivici, V. M. Vukovic, R. Bradley, M. D. Karol, Y. Chen, W. Guo, T. Inoue and L. S. Rosen, BMC Cancer, 2013, 13, 152-161.
7. R. Bagatell, G. D. Paine-Murrieta, C. W. Taylor, E. J. Pulcini, S. Akinaga, I. J. Benjamin and L. Whitesell, Clin. Cancer Res., 2000, 6, 3312-3318.
8. H. Reikvam, K. J. Hatfield, E. Ersvaer, R. Hovland, J. Skavland, B. T. Gjertsen, K. Petersen and O. Bruserud, Br. J. Haematol., 2012, 156, 468-480.
9. M. V. Powers, K. Jones, C. Barillari, I. Westwood, R. L. van Montfort and P. Workman, Cell Cycle, 2010, 9, 1542-1550.
10. P. workman, B. Al-Lazikani and P. A. Clarke, Curr. Opin. Pharmacol., 2013, 13, 486-496.
11. P. Workman and B. Al-Lazikani, Nat. Rev. Drug Discovery, 2013, 12, 889-890.
12. M. V. Powers, M. Valenti, S. Miranda, A. Maloney, S. A. Eccles, G. Thomas, P. A. Clarke and P. Workman, Onco Targets Ther., 2013, 4, 1963-1975.
13. P. Workman, P. A. Clarke and B. Al-Lazikani, Cancer Cell, 2012, 21, 455-458.
14. B. Samarasinghe, C. T. K. Wales, F. R. Taylor and A. T. Jacobs, Biochem. Pharmacol., 2014, 87, 445-455.
15. J. Anckar and L. Sistonen, Annu. Rev. Biochem., 2011, 80, 1089-1115.
16. M. L. Mendillo, S. Santagata, M. Koeva, G.W. Bell, R. Hu, R. M. Tamimi, E. Fraenkel, T. A. Ince, L. Whitesell and S. Lindquist, Cell, 2012, 150, 549-562.
17. J. M. McConnell, L. D. Alexander and S. R. McAlpine, Bioorg. Med. Chem. Lett., 2014, 24, 661-666.
18. Y. C. Koay, J. R. McConnell, Y. Wang, S. J. Kim and S. R. McAlpine, ACS Med. Chem. Lett., 2014, 5, 771-776.
19. J. B. Kunicki, M. N. Petersen, L. D. Alexander, V. C. Ardi, J. R. McConnell and S. R. McAlpine, Bioorg. Med. Chem. Lett., 2011, 21, 4716-4719.
20. V. C. Ardi, L. D. Alexander, V. A. Johnson and S. R. McAlpine, ACS Chem. Biol., 2011, 6, 1357-1367.
21. L. D. Alexander, J. R. Partridge, D. A. Agard and S. R. McAlpine, Bioorg. Med. Chem. Lett., 2011, 21, 7068-7071.
22. R. C. Vasko, R. A. Rodriguez, C. N. Cunningham, V. C. Ardi, D. A. Agard and S. R. McAlpine, ACS Med. Chem. Lett., 2010, 1, 4-8.
23. S. Manni, A. Brancalion, L. Q. Tubi, A. Colpo, L. Pavan, A. Cabrelle, E. Ave, F. Zaffino, G. Di Maira, M. Ruzzene, F. Adami, R. Zambello, M. R. Pitari, P. Tassone, L. A. Pinna, C. Gurrieri, G. Semenzato and F. Piazza, Clin. Cancer Res., 2012, 18, 1888-1900.
24. E. de Billy, P. Clarke and P. Workman, Cancer Cell, 2013, 24, 147-149.
25. L. Wei, T. Liu, H. Wang, H. Hong, A. Yu, H. Feng and W. Chang, Breast Cancer Res., 2011, 13, R101.
26. R. P. Sellers, L. D. Alexander, V. A. Johnson, C.-C. Lin, J. Savage, R. Corral, J. Moss, T. S. Slugocki, E. K. Singh, M. R. Davis, S. Ravula, J. E. Spicer, J. L. Oelrich, A. Thornquist, C.-M. Pan and S. R. McAlpine, Bioorg. Med. Chem., 2010, 18, 6822-6856.
27. D. Mahalingam, R. Swords, J. S. Carew, S. T. Nawrocki, K. Bhalla and F. J. Giles, Br. J. Cancer, 2009, 100, 1523-1529.